Chitin Whisker-Enhanced Hyaluronic Acid Cell Scaffold and Preparation Method Thereof

    公开(公告)号:US20220081492A1

    公开(公告)日:2022-03-17

    申请号:US17106194

    申请日:2020-11-30

    IPC分类号: C08B37/08 C12M1/12

    摘要: Provided are a chitin whisker-enhanced hyaluronic acid cell scaffold and a preparation method thereof. Components of the cell scaffold include chitin whiskers and cross-linked hyaluronic acid. The chitin whisker-enhanced hyaluronic acid cell scaffold is obtained by dispersing chitin whiskers into deionized water using ultrasound, followed by addition of hyaluronic acid and uniform mixing to obtain an aqueous solution, adjusting a pH value of the aqueous solution to be in a range of 4.0 to 6.0, subjecting the aqueous solution to a cross-linking reaction, dialyzing a reaction product in a phosphate buffer solution, and freeze drying a resulting product. The chitin whisker-enhanced hyaluronic acid cell scaffold and the preparation method thereof can increase a mechanical property and a resistance to degradation of a scaffold material and expand an application scope of hyaluronic acid cell scaffolds.

    COLLAGEN MELANOCYTE COMPLEX, PREPARATION METHOD AND USE THEREOF

    公开(公告)号:US20210154363A1

    公开(公告)日:2021-05-27

    申请号:US16834220

    申请日:2020-03-30

    IPC分类号: A61L27/24 A61L27/36

    摘要: The present disclosure provides a preparation method of a collagen melanocyte complex and use of the collagen melanocyte complex. The collagen material is a scaffold material with good biocompatibility, mechanical properties, and degradation performance, which is prepared based on tissue engineering technology. The present disclosure relates to the preparation of a collagen scaffold and the construction of a collagen melanocyte complex. Melanocytes on the scaffold material have higher cell activity and better melanin secretion ability. The collagen melanocyte complex avoids the loss of cell suspension during cell transplantation and provides a good three-dimensional growth environment for cells. The collagen melanocyte complex prepared by the present disclosure can be used in patients with vitiligo or patients with pigment deficiency and epidermal damage.